Literature DB >> 9598003

Autologous human collagen and dermal fibroblasts for soft tissue augmentation.

T B West1, T S Alster.   

Abstract

BACKGROUND: Augmentation of soft tissue defects can be achieved through intradermal injection of silicone, animal collagen, plasma-gelatin mixture, and fat. Due to their rapid degradation in vivo, however, clinical effects are typically transient. The use of autologous human collagen could conceivably result in sustained clinical improvement due to decreased collagen degradation.
OBJECTIVE: The purpose of this study was to determine whether prolonged dermal correction could be achieved through injection of autologous human fibroblasts.
RESULTS: Significant sustained clinical improvement was observed in two of the original 12 patients entered into the study. The nasolabial fold region was shown to be the most responsive facial area to treatment.
CONCLUSIONS: The use of injectable autologous human collagen for soft tissue correction remains an intriguing prospect. While the findings of this study indicate possible sustained clinical improvement using this autologous system in some patients, it remains difficult to predict the degree and duration of individual response in various areas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598003     DOI: 10.1111/j.1524-4725.1998.tb04198.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

1.  Improved enzymatic isolation of fibroblasts for the creation of autologous skin substitutes.

Authors:  Hongjun Wang; Clemens A Van Blitterswijk; Marion Bertrand-De Haas; Arnold H Schuurman; Evert N Lamme
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

2.  Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.

Authors:  En Kimura; Jay J Han; Sheng Li; Brent Fall; Jennifer Ra; Miki Haraguchi; Stephen J Tapscott; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2008-05-29       Impact factor: 6.150

3.  Soft tissue augmentation by autologous cultured fibroblasts transplantation for treatment of wrinkles and scars: a case series of 20 patients.

Authors:  Mohammad Ali Nilforoushzadeh; Amir Hossein Siadat; Mojgan Arianrad; Fariba Moulavi; Elahe Haft Baradaran; Mohhamad Hossein Nasr Esfahani
Journal:  J Res Med Sci       Date:  2010-05       Impact factor: 1.852

4.  Long-Term Follow-up of Autologous Fibroblast Transplantation for Facial Contour Deformities, A Non-Randomized Phase IIa Clinical Trial.

Authors:  Amir Bajouri; Zahra Orouji; Ehsan Taghiabadi; Abdoreza Nazari; Atefeh Shahbazi; Nasrin Fallah; Parvaneh Mohammadi; Mohammad Rezvani; Zahra Jouyandeh; Fatemeh Vaezirad; Zahra Khalajasadi; Mahshid Ghasemi; Aslan Fanni; Sara Haji Hosseinali; Ahad Alizadeh; Hossein Baharvand; Saeed Shafieyan; Nasser Aghdami
Journal:  Cell J       Date:  2019-09-08       Impact factor: 2.479

Review 5.  Application of Nonsurgical Modalities in Improving Facial Aging.

Authors:  Kelun Li; Fanyu Meng; Yu Ru Li; Yueyi Tian; Hao Chen; Qi Jia; HongXin Cai; Heng Bo Jiang
Journal:  Int J Dent       Date:  2022-02-24

Review 6.  Alteration of skin properties with autologous dermal fibroblasts.

Authors:  Rajesh L Thangapazham; Thomas N Darling; Jon Meyerle
Journal:  Int J Mol Sci       Date:  2014-05-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.